Reply to "Upset - maybe misdiagnosed and biologics concerns"

The story continues, as these things go. I continue to feel better. MRE on Monday. 

Just a tidbit to share that I received from Prometheus:


The sensitivity of our IBD panel is 72% which is posted at the bottom of the report. This indicates that we are unable to detect IBD in ~28% of IBD positive patients. The UC marker ANCA antibody is produced in the large bowel, so with resection, this reduces our ability to detect IBD / UC.

The positive outcome of a negative IBD result, is that the initial diagnosis is more likely.

Copyright © 2019 The J-Pouch Group. All rights reserved.
×
×
×
×